Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ke-Xin Wang has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Guo-Mei Xia

    The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China

    1 shared publication
  • Sheng-Qun Deng

    Department of Pathogen Biology, Anhui Province Key Laboratory of Zoonoses, The Provincial Key Laboratory of Zoonoses of High Institutions in Anhui, School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China

    1 shared publication
  • Shuai-Ru Jiao

    Department of Pathogen Biology, School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China

    1 shared publication
  • Yu-Han Liu

    Department of Pathogen Biology, School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China

    1 shared publication
  • Yufeng Gao

    Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China

    1 shared publication

Latest Publications

  • Top Cited Papers
    Open Access

    Clinical Predictors of Mortality in Severe Fever with Thrombocytopenia Syndrome: An Updated Systematic Review and Meta-Analysis

    by Ke-Xin Wang, Guo-Mei Xia, Yu-Han Liu, Shuai-Ru Jiao, Yu-Feng Gao, Sheng-Qun Deng

    Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne disease with a high case fatality rate and no specific treatment. Identifying robust clinical predictors of mortality is crucial for improving patient outcomes. This systematic review and meta-analysis aimed to comprehensively evaluate the association of underlying diseases, hemorrhagic symptoms, neurological signs, and complications with fatal outcomes in SFTS patients. We systematically searched PubMed, Web of Science, CNKI, and Wan Fang databases up to 1 March 2026 for observational studies. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using fixed- or random-effects models. Forty-five studies, encompassing 8078 patients (1729 deaths), were included. Underlying diabetes (OR = 1.77) and hypertension (OR = 2.38) were significant risk factors. Among hemorrhagic symptoms, systemic manifestations (OR = 4.19), melena (OR = 4.26), and petechiae (OR = 3.20) were strong predictors. Neurological symptoms, particularly coma (OR = 55.07), were the most powerful predictors of death. Complications like multiple organ dysfunction syndrome (MODS, OR = 19.77) and disseminated intravascular coagulation (DIC, OR = 12.02) also significantly increased mortality risk. The findings confirm that a range of clinical features, from underlying conditions to severe neurological and organ complications, are strongly associated with SFTS mortality. These predictors can guide clinicians in early risk stratification and intensive monitoring, especially in high-risk patients, to potentially reduce the high case-fatality rate.